Form 8-K · Current report
Procter & Gamble 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0000080424
- Accession no.
- 0000080424-26-000094
Summary
Procter & Gamble announced that Shailesh Jejurikar, its President and Chief Executive Officer, will take on the additional role of Chairman of the Board effective August 1, 2026, while Executive Chairman Jon R. Moeller retires from the board on July 31, 2026 and from the company on August 14, 2026 after 38 years. The board's non-employee directors also reappointed Joseph Jimenez as independent Lead Director.
Key points
- Jejurikar joined P&G in 1989 and has been a member of its global leadership team since 2014, having led businesses including global Fabric Care and Home Care.
- Moeller previously served as Executive Chairman, CEO, COO and CFO during his 38 years at the company.
- Jejurikar will serve as Chairman at the pleasure of the board, in addition to his current responsibilities.
- Jejurikar credited Moeller's strategic vision with shaping the company as it is today.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On July 29, 2026, The Procter & Gamble Company (the "Company") announced that Jon R. Moeller, Executive Chairman of the Board, will retire from his position as Executive Chairman and as a member of the Board of Directors (“the Board”), effective July 31, 2026. Mr. Moeller will remain with the Company through August 14, 2026, when he will retire from the Company. The Company also announced that Shailesh G. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.